Overview A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers Status: Recruiting Trial end date: 2021-11-30 Target enrollment: Participant gender: Summary The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of different dose levels of PRV-002 in Health Volunteers Phase: Phase 1 Details Lead Sponsor: Odyssey Group International, Inc.Collaborator: Avance Clinical Pty Ltd.